• DRAMP ID

    • DRAMP29043
    • Peptide Name

    • Oncocin (variant of Oncopeltus antibacterial peptide 4)
    • Source

    • Synthetic construct (Oncocin is a variant of the 2 kDa Oncopeltus antibacterial peptide 4, which was originally isolated from oncopeltus fasciatus (milkweed bug))
    • Family

    • Not found
    • Gene

    • N/A
    • Sequence

    • VDKPPYLPRPRPPRRIYNR
    • Sequence Length

    • 19
    • UniProt Entry

    • No entry found
    • Protein Existence

    • Synthetic form
    • Biological Activity

    • Antimicrobial, Antibacterial, Anti-Gram-
    • Target Organism

      • [Ref.20565063] Gram-negative pathogens: P.aeruginosa DSM3227 (MIC = 4 μg/mL), P. aeruginosa Walter (MIC = 8 μg/mL), P. aeruginosa ATCC27853 (MIC = 4 μg/mL), P. aeruginosa PAO1 (MIC = 2 μg/mL), P. aeruginosa 60811001 (MIC = 2 μg/mL), P. aeruginosa 60909001 (MIC = 2 μg/mL), P. aeruginosa 61118003 (MIC = 2 μg/mL), P. aeruginosa 70108001 (MIC = 4 μg/mL), E. coli 70329001 (MIC = 1 μg/mL), E. coli 70430001 (MIC = 1 μg/mL), E. coli 70419002 (MIC = 8 μg/mL), E. coli 70502001 (MIC = 1 μg/mL), E. coli Neumann (MIC = 2 μg/mL), E. coli 205024 (MIC = 4 μg/mL), E. coli 455/7 (MIC = 0.5 μg/mL), E. coli 8474 (MIC = 0.5 μg/mL), K. pneumoniae DSM681 (MIC = 0.25 μg/mL), K. pneumoniae 57 USA (MIC = 0.25 μg/mL), K. pneumoniae 63 (MIC = 8 μg/mL), K. pneumoniae 8085 (MIC = 0.5 μg/mL), K. pneumoniae ATCC12657 (0.5 μg/mL), K. pneumoniae ATCC27799 (MIC = 1 μg/mL), A. baumannii ICB14067 (MIC = 1 μg/mL), A. baumannii ICB14072 (MIC = 1 μg/mL), A. baumannii ICB14073 (MIC = 2 μg/mL), A. baumannii ICB9250 (MIC = 0.5 μg/mL), A. baumannii M17 (MIC = 1 μg/mL), E. cloacae 34654 (MIC = 0.25 μg/mL), E. cloacae Ha088 (MIC = 0.125 μg/mL), E. cloacae Ha089 (0.125 μg/mL), E. cloacae Ha185 (MIC = 0.5 μg/mL), E. cloacae Ha89 (MIC = 0.25 μg/mL), P. vulgaris ICB9081 (MIC = 4 μg/mL), P. vulgaris ICB9095 (MIC = 4 μg/mL), Stenotrophomonas ICB308054 (MIC = 32 μg/mL), Stenotrophomonas ICB7569 (MIC = 8 μg/mL), Stenotrophomonas ICB7789 (MIC = 32 μg/mL)
    • Hemolytic Activity

      • [Ref.20565063]None of the tested peptides showed any hemolytic activity against human erythrocytes in the studied peptide concentration range up to 600 μg/mL.
    • Cytotoxicity

      • [Ref.20565063] Oncocin showed no toxic effects on HeLa- or neuronal-cell-like differentiated SH-SY5Y cells at a peptide concentration of 600 μg/mL, which was about 100-fold above their MIC-values against E.coli BL21 AI.
    • Binding Target

    • Bacterial ribosome
    • Linear/Cyclic

    • Linear
    • N-terminal Modification

    • Free
    • C-terminal Modification

    • Amidation
    • Nonterminal Modifications and Unusual Amino Acids

    • None
    • Stereochemistry

    • L
    • Structure

    • Not found
    • Structure Description

    • Not found
    • Helical Wheel Diagram

    • DRAMP29043 helical wheel diagram
    • PDB ID

    • None
    • Predicted Structure

    • There is no predicted structure for DRAMP29043.
    • Formula

    • C109H176N36O25
    • Absent Amino Acids

    • ACEFGHMQSTW
    • Common Amino Acids

    • P
    • Mass

    • 2390.82
    • PI

    • 11.45
    • Basic Residues

    • 6
    • Acidic Residues

    • 1
    • Hydrophobic Residues

    • 3
    • Net Charge

    • +5
    • Boman Index

    • -8191
    • Hydrophobicity

    • -1.742
    • Aliphatic Index

    • 56.32
    • Half Life

      • Mammalian:100 hour
      • Yeast:>20 hour
      • E.coli:>10 hour
    • Extinction Coefficient Cystines

    • 2980
    • Absorbance 280nm

    • 165.56
    • Polar Residues

    • 3

DRAMP29043

DRAMP29043 chydropathy plot
    • Comment

    • Oncocin inhibits bacterial protein translation by targeting the ribosome.
  • ·Literature 1
    • Title

    • Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): A Novel Antibacterial Peptide Optimized against Gram-Negative Human Pathogens
    • Reference

    • J Med Chem. 2010 Jul 22;53(14):5240-7. doi: 10.1021/jm100378b.
    • Author

    • Daniel Knappe, Stefania Piantavigna, Anne Hansen, Adam Mechler, Annegret Binas, Oliver Nolte, Lisandra L Martin, Ralf Hoffmann